2019 Power 50: Shantanu Gaur
More Information
At a time when the U.S. Centers for Disease Control & Prevention says roughly two out of five American adults are obese, helping people lose weight is a major challenge for the healthcare industry. At the 100-employee company Allurion, Gaur is leading a firm that’s already developed a weight-loss product used in 12 countries in Europe and the Middle East and treated 10,000 people. The Elipse Balloon is swallowed in a capsule and filled through a catheter with fluid to expand to around the size of a fist – about half of a stomach.
Compared to lap-bands or other weight-loss devices, the Elipse is swallowed during a brief office visit without a procedure, and after four months, a polymer on one end of the balloon wears away, causing the balloon to deflate and then pass naturally through the body. Allurion is hoping for U.S. Food & Drug Administration approval by 2020 and has raised $50 million in private financing.
Where is Central Mass. headed? Healthcare innovation has become the lifeblood of the economy. Central Mass. stands to contribute valuable human, financial and social capital to the state’s healthcare ecosystem.
The pen is mightier than the keyboard: Writing letters is a lost art, and I write one to someone every year!
Check out each member of WBJ's Power 50 Class of 2019
WBJ Web Partners
Most Recent
Most Recent
0 Comments